ad image
CDMO Market Insight, Pricing and Benchmarking Reports
NICE INSIGHT REPORT

Microbial Fermentation, Biologics:2024 Market Insight, CDMO Pricing and Benchmarking

Published July 2024
  • 2024 pricing data for benchmarking and informed decision-making
  • Regional breakdown of pricing: Americas, Europe, APAC
  • 158 pages of relevant market insights, research, and analysis
  • 42 profiles of biologics CDMOs specializing in microbial fermentation
  • Deep focus into microbial cell culture-based therapeutics, such as cytokines and growth factors
  • Emerging trends and technologies shaping the future of the market

Key market insights for innovators, CDMOs and investors in the biologics industry.

Essential CDMO market intelligence and pricing data

Essential CDMO market intelligence and pricing data

Unlock the biologics market with insights into manufacturing trends and a comprehensive study of the top CDMOs specializing in microbial fermentation of therapeutics. Benchmark your business from development to manufacture with our in-depth pricing studies, which use years of primary data.

Scientific analysis on microbial fermentation-based biologics

Scientific analysis on microbial fermentation-based biologics

Our Market Insight report provides unique analyses into biologics produced in microbial cell culture, such as cytokines and growth factors. Hear from PhD scientists, KOLs, and respected market voices discuss developing microbial fermentation-based biologics and the disruptive technologies forging the future of healthcare.

Published July 2024

Our Market Insight provides research, data and analysis from PhD scientists and respected voices in biopharma.

The Microbial Fermentation, Biologics: 2024 Market Insight, CDMO Pricing and Benchmarking provides

42 profiles of CDMOs
42 profiles of CDMOs specializing in microbial fermentation
Competitive benchmarking
Competitive benchmarking of pricing and capabilities for companies all over the world, broken down by global region
Scientific analysis
Scientific analysis of the clinical trials for insulin and GLP-1 agonists, including format, sponsors, and indications
Unique benefits and complexities
Unique benefits and complexities to microbial fermentation-based biologics
Market growth projections
Market growth projections for the biologics market, with distinct therapeutic segments such as cytokines and growth factors
Investment outlook
Investment outlook analyzing economic and regulatory conditions

Over 1000 hours of data collection and analysis —

including interviews with CDMO owners, PhDs and customers.